Stay updated on Pembrolizumab for Mycosis Fungoides Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.

Latest updates to the Pembrolizumab for Mycosis Fungoides Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference2%
- Check18 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, signaling a new release; 'Back to Top' was removed as a minor UI change.SummaryDifference0.1%
- Check40 days agoChange DetectedThe page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous version, v3.0.0, has been removed from the page.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has been updated to include new information about mycosis fungoides and Sézary syndrome, including the mSWAT scoring system and the addition of specific dates and facility details, while removing some previous location-related terms and outdated references.SummaryDifference3%
- Check61 days agoChange DetectedThe webpage has been updated to reflect new results and timelines for a clinical trial involving Pembrolizumab in treating Mycosis Fungoides, with significant changes in the reporting dates and the duration of various response metrics.SummaryDifference19%
Stay in the know with updates to Pembrolizumab for Mycosis Fungoides Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.